Active Ingredient(s): Trientine
FDA Approved: * November 8, 1985
Pharm Company: * MERCK
Category: Genetic Disorders

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Syprine Overview

Triethylenetetramine (TETA and trien), also called trientine (INN), is an organic compound with the formula [CH2NHCH2CH2NH2]2. This oily liquid is colorless but, like many amines, older samples assume a yellowish color due to impurities resulting from air-oxidation. It is soluble in polar solvents. The branched isomer tris(2-aminoethyl)amine and piperazine derivatives may also be present in commercial samples of TETA.[9] Contents 1 Uses 1.1 Medical uses 2 Society and cul...

Read more Syprine Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Syprine Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Capsule: 250mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Syprine: (2 results)

Sorted by National Drug Code
  • 0187-2120 Syprine 250 mg Oral Capsule by Valeant Pharmaceuticals North America LLC
  • 25010-710 Syprine 250 mg Oral Capsule by Aton Pharma, Inc.

Other drugs which contain Trientine or a similar ingredient: (3 results)